Protections for clinical trials in low and middle income countries need strengthening not weakening

The latest revision of the Declaration of Helsinki weakens protections for trial participants in low and middle income countries. Rafael Dal-Ré and colleagues argue that this is a step in the wrong direction

Detalles Bibliográficos
Autores principales: Dal-Ré, Rafael, Ndebele, Paul, Higgs, Elizabeth, Sewankambo, Nelson, Wendler, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2014
Materias:
Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688422/
https://www.ncbi.nlm.nih.gov/pubmed/24996885
http://dx.doi.org/10.1136/bmj.g4254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688422/
https://www.ncbi.nlm.nih.gov/pubmed/24996885
http://dx.doi.org/10.1136/bmj.g4254

Ejemplares similares